NO953847L - (5)-alfafenyl-2-pyridinetanaminbenzoat og dets anvendelse som legemiddel - Google Patents

(5)-alfafenyl-2-pyridinetanaminbenzoat og dets anvendelse som legemiddel

Info

Publication number
NO953847L
NO953847L NO953847A NO953847A NO953847L NO 953847 L NO953847 L NO 953847L NO 953847 A NO953847 A NO 953847A NO 953847 A NO953847 A NO 953847A NO 953847 L NO953847 L NO 953847L
Authority
NO
Norway
Prior art keywords
benzoate
alphafenyl
pyridinethanamine
drug
anticonvulsant
Prior art date
Application number
NO953847A
Other languages
English (en)
Other versions
NO304648B1 (no
NO953847D0 (no
Inventor
Robert John Murray
Donald Mathisen
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB1993/000689 external-priority patent/WO1993020052A1/en
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO953847D0 publication Critical patent/NO953847D0/no
Publication of NO953847L publication Critical patent/NO953847L/no
Publication of NO304648B1 publication Critical patent/NO304648B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO953846A 1993-04-01 1995-09-28 (S)-alfa-fenyl-2-pyridinetanaminbenzoat, farmasoeytisk preparat inneholdende denne forbindelsen og dens anvendelse til fremstilling av legemiddel NO304648B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/GB1993/000689 WO1993020052A1 (en) 1992-04-03 1993-04-01 Enantiomeric 1-phenyl-2-(2-pyridinyl)ethylamine for the treatment of neurodegenerative disorders
PCT/GB1994/000716 WO1994022832A1 (en) 1993-04-01 1994-04-05 (s)-alpha-phenyl-2-pyridineethanamine benzoate and its use as a medicament

Publications (3)

Publication Number Publication Date
NO953847D0 NO953847D0 (no) 1995-09-28
NO953847L true NO953847L (no) 1995-11-22
NO304648B1 NO304648B1 (no) 1999-01-25

Family

ID=10728731

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953846A NO304648B1 (no) 1993-04-01 1995-09-28 (S)-alfa-fenyl-2-pyridinetanaminbenzoat, farmasoeytisk preparat inneholdende denne forbindelsen og dens anvendelse til fremstilling av legemiddel

Country Status (13)

Country Link
EP (1) EP0691958B1 (no)
JP (1) JP3023988B2 (no)
AT (1) ATE156814T1 (no)
AU (1) AU682350B2 (no)
CA (1) CA2159480C (no)
DE (1) DE69404975T2 (no)
DK (1) DK0691958T3 (no)
ES (1) ES2105679T3 (no)
FI (1) FI109019B (no)
GR (1) GR3025082T3 (no)
NO (1) NO304648B1 (no)
WO (1) WO1994022832A1 (no)
ZA (1) ZA942140B (no)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3422191A (en) * 1965-01-21 1969-01-14 Synergistics Inc Compositions and methods for tranquilization employing salts of n-morpholine ethanol
GB9320273D0 (en) * 1993-04-01 1993-11-17 Fisons Corp Compound useful in therapy
ATE135206T1 (de) * 1988-08-12 1996-03-15 Astra Ab Arylalkylamine und -amide mit krampflösender und nervenschützender wirkung
JP2514855B2 (ja) * 1990-08-08 1996-07-10 キッセイ薬品工業株式会社 光学活性なアラニンアニリド誘導体の酸付加塩
DK0633879T3 (da) * 1992-04-03 1998-09-28 Astra Ab Enantiomert 1-phenyl-2(2-pyridinyl) ethylamin til behandling af neurodegenerative sygdomme

Also Published As

Publication number Publication date
DE69404975T2 (de) 1997-12-18
FI954646A0 (fi) 1995-09-29
FI109019B (fi) 2002-05-15
NO304648B1 (no) 1999-01-25
NO953847D0 (no) 1995-09-28
EP0691958A1 (en) 1996-01-17
GR3025082T3 (en) 1998-01-30
AU6433794A (en) 1994-10-24
ZA942140B (en) 1994-10-03
DK0691958T3 (da) 1997-12-08
ATE156814T1 (de) 1997-08-15
JP3023988B2 (ja) 2000-03-21
CA2159480C (en) 2005-01-25
CA2159480A1 (en) 1994-10-13
EP0691958B1 (en) 1997-08-13
FI954646A (fi) 1995-11-29
ES2105679T3 (es) 1997-10-16
WO1994022832A1 (en) 1994-10-13
JPH08508475A (ja) 1996-09-10
AU682350B2 (en) 1997-10-02
DE69404975D1 (de) 1997-09-18

Similar Documents

Publication Publication Date Title
DE69434376D1 (de) Videotrainingsverfahren und display
AU2466695A (en) The use of famotidine and related compounds in the treatment of movement disorders
ITRM910002A0 (it) Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.
GB9219425D0 (en) Therapeutic agent and its use
BG101605A (en) Enterokinetic benzamide
DE69422126T2 (de) Flüssigkristallzusammensetzung, Flüssigkristallvorrichtung und diese verwendende Vorrichtung
NO953846L (no) (S)-alfa-fenyl-2-pyridinetanamin (S)-malat og dets anvendelse som legemiddel
AU5963396A (en) Cis-resorcylide, pharmaceutical composition containing it, use thereof in the treatment of thrombosis and related disorders
ITMI930341A1 (it) Impiego terapeutico del pirrolidon carbossilato di piridossina
NO953847D0 (no) (5)-alfafenyl-2-pyridinetanaminbenzoat og dets anvendelse som legemiddel
IT1273202B (it) Procedimento e dispositivo per la microfinitura di ruote dentate
ITRM910796A1 (it) Impiego di l-carnitina e acil l-carnitine nel trattamento delle oligoastenospermie idiopatiche.
EP0893123A4 (en) MEANS OF PREVENTIVE AND CURATIVE TREATMENT OF CONDITIONS RELATED TO DIFFERENT FORMS OF AGING OF THE ORGANISM
FR2702151B1 (fr) Application d'anticonvulsivants dans le traitement du neuro-sida.
ITFI920241A0 (it) Impiego della melatonina nella terapia della sclerosi sistematica, della sarcoidosi ed altro
ID15808A (id) Penggunaan protease dibidang kedokteran
GB9321063D0 (en) Analgesic agent and its use
ITFI930032A0 (it) Prodotto destinato al trattametno e alla prevenzione della alpecia e suo procedimento di preparazione.

Legal Events

Date Code Title Description
MK1K Patent expired